Harvard Bioscience Revenue, Profits - HBIO Quarterly Income Statement

Add to My Stocks
$5.03 $0.07 (1.37%) HBIO stock closing price Jun 18, 2018 (Closing)

Financial analysis of Harvard Bioscience involves more than just checking the Harvard Bioscience stock price, by looking at the financial statements of the company in detail. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. Like any other income statement, the HBIO income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a QoQ revenue decline of -2.55% when compared to the same period in the past. Along with Harvard Bioscience assets and Harvard Bioscience free cash flow, Harvard Bioscience profits as shown in profit and loss statement give key insights about the business. The net profit for 2018 Q1 is $-4.06M and the 2018 Q1 revenue is $26.76M.

View and download details of revenue and profits for Harvard Bioscience for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Harvard Bioscience Revenues or Net Sales
Cost Of Goods Sold (COGS)13.49M14.3M13.41M13.92M12.65M14.32M13.31M14.46M14.01M15.46M
Harvard Bioscience Gross Profit
Research & Development Expense2.4M1.54M1.53M1.29M1.28M1.17M1.3M1.5M1.42M1.55M
Selling General & Admin Expense11.03M10.37M9.61M9.38M10.25M11.45M10.46M10.32M11.06M10.61M
Income Before Depreciation Depletion Amortization-0.16M1.29M---0.03M-0.49M-0.08M-0.15M--
Depreciation Depletion Amortization1.1M---------
Non Operating Income-3.08M-0.67M-0.08M-0.28M-0.24M----0.05M-0.23M
Interest Expense----------
Harvard Bioscience Pretax Income
Provision for Income Taxes--1.17M--0.08M----0.05M-16.8M
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-5.85M1M-0.42M-0.38M-1.07M-1.32M-1.64M-0.71M-0.64M-17.14M
Extraordinary Items & Discontinued Operations1.79M---------
Harvard Bioscience Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS35.46M36.06M34.84M34.7M34.58M34.38M34.33M34.13M34.01M33.95M
Average Shares used to compute Basic EPS35.46M34.89M34.84M34.7M34.58M34.38M34.33M34.13M34.01M33.95M
Income Before Nonrecurring Items-1.42M---0.15M-----
Income from Nonrecurring Items-6.1M-0.42M-0.66M-0.66M-0.92M-1.78M-2.13M-1.7M-1.57M-17.6M
Harvard Bioscience Earnings Per Share Basic Net
Harvard Bioscience Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.
Preferred Dividends Acc Pd----------
Dividends Common0.000.00--------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on Harvard Bioscience stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that HBIO stock has a topline or revenue of $26.76M for 2018 Q1 as per this Harvard Bioscience revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. HBIO stock had a poor bottom line growth.

The income statement is also called the profit and loss statement. Apart from the HBIO income statement, one can check the Harvard Bioscience historical stock prices to check how the price has moved with time.

Harvard Bioscience Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield